|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-12-9
|
|
pubmed:abstractText |
Major surgery impairs the cellular immune response. In order to stimulate the immunological system during the perioperative period, we have studied the clinical and biological tolerance, and the immunological and histological effects of a perioperative treatment using progressive doses of Interferon-alpha 2a, from the third preoperative day (D-3) until the tenth postoperative day (D10).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0020-8868
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9331846-Adolescent,
pubmed-meshheading:9331846-Adult,
pubmed-meshheading:9331846-Aged,
pubmed-meshheading:9331846-Analysis of Variance,
pubmed-meshheading:9331846-Antineoplastic Agents,
pubmed-meshheading:9331846-Dose-Response Relationship, Drug,
pubmed-meshheading:9331846-Female,
pubmed-meshheading:9331846-Fever,
pubmed-meshheading:9331846-Humans,
pubmed-meshheading:9331846-Interferon-alpha,
pubmed-meshheading:9331846-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:9331846-Killer Cells, Natural,
pubmed-meshheading:9331846-Lymphocyte Count,
pubmed-meshheading:9331846-Lymphocyte Subsets,
pubmed-meshheading:9331846-Male,
pubmed-meshheading:9331846-Middle Aged,
pubmed-meshheading:9331846-Neoplasms,
pubmed-meshheading:9331846-Perioperative Care,
pubmed-meshheading:9331846-Prospective Studies,
pubmed-meshheading:9331846-Recombinant Proteins
|
|
pubmed:articleTitle |
Tolerance and feasibility of perioperative treatment with interferon-alpha 2a in advanced cancers.
|
|
pubmed:affiliation |
Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
